S&P 500
(-0.08%) 5 183.56 points
Dow Jones
(0.19%) 38 959 points
Nasdaq
(-0.25%) 16 292 points
Oil
(0.78%) $78.99
Gas
(0.41%) $2.22
Gold
(0.15%) $2 327.60
Silver
(0.46%) $27.67
Platinum
(-0.29%) $985.50
USD/EUR
(0.06%) $0.930
USD/NOK
(-0.06%) $10.89
USD/GBP
(0.08%) $0.800
USD/RUB
(0.76%) $92.14

Actualizaciones en tiempo real para Renalytix AI plc [RNLX]

Bolsa: NASDAQ Sector: Healthcare Industria: Health Information Services
BUY
100.00%
return 3.48%
SELL
100.00%
return -0.88%
Última actualización8 may 2024 @ 12:00

-3.82% $ 0.665

VENDER 120671 min ago

@ $1.190

Emitido: 14 feb 2024 @ 15:54


Retorno: -44.11%


Señal anterior: feb 14 - 13:31


Señal anterior: Comprar


Retorno: 3.48 %

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 12:00):

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score...

Stats
Volumen de hoy 122 760
Volumen promedio 1.90M
Capitalización de mercado 51.33M
EPS $-0.110 ( 2023-11-14 )
Próxima fecha de ganancias ( $-0.0800 ) 2024-06-14
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.740
ATR14 $0.00100 (0.15%)
Insider Trading
Date Person Action Amount type
2024-04-24 Icahn School Of Medicine At Mount Sinai Buy 9 360 374 Ordinary Shares
2023-11-20 Coste Catherine Buy 95 000 Employee Stock Option (right to buy)
2023-11-20 Levangie Daniel J Buy 95 000 Employee Stock Option (right to buy)
2023-11-20 Parikh Chirag R. Buy 95 000 Employee Stock Option (right to buy)
2023-11-20 Mills Christopher Buy 95 000 Employee Stock Option (right to buy)
INSIDER POWER
84.35
Last 27 transactions
Buy: 12 713 670 | Sell: 1 641 743

Volumen Correlación

Largo: -0.19 (neutral)
Corto: -0.32 (neutral)
Signal:(37.474) Neutral

Renalytix AI plc Correlación

10 Correlaciones Más Positivas
PUCK0.925
NVCN0.921
TWLV0.92
TWCB0.92
KSICU0.919
GXII0.918
OVID0.917
UBFO0.916
TBLA0.915
KVSA0.914
10 Correlaciones Más Negativas
AMGN-0.943
NAKD-0.921
CYTO-0.921
AHPI-0.913
HCAQ-0.909
PROC-0.905
LAWS-0.905
THMA-0.896
PCSA-0.894
LSAQ-0.892

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Renalytix AI plc Correlación - Moneda/Commodity

The country flag -0.53
( weak negative )
The country flag -0.01
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.84
( strong negative )

Renalytix AI plc Finanzas

Annual 2023
Ingresos: $3.40M
Beneficio Bruto: $701 000 (20.60 %)
EPS: $-1.120
FY 2023
Ingresos: $3.40M
Beneficio Bruto: $701 000 (20.60 %)
EPS: $-1.120
FY 2022
Ingresos: $2.97M
Beneficio Bruto: $918 000 (30.91 %)
EPS: $-1.560
FY 2021
Ingresos: $1.49M
Beneficio Bruto: $633 000 (42.45 %)
EPS: $-0.860

Financial Reports:

No articles found.

Renalytix AI plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico